Evaxion to announce business update and first quarter 2025 financial results on may 27, 2025

Copenhagen, denmark, may 23, 2025 - evaxion a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, will provide a business update and report its first quarter 2025 financial results on tuesday, may 27, 2025, before opening of the nasdaq cm.

EVAX Ratings Summary

EVAX Quant Ranking